2017
DOI: 10.1038/s41598-017-17910-0
|View full text |Cite
|
Sign up to set email alerts
|

Magnolol inhibits venous remodeling in mice

Abstract: Due to gravity the venous vasculature in the lower extremities is exposed to elevated pressure levels which may be amplified by obesity or pregnancy. As a consequence, venules dilate and may be slowly transformed into varicose or spider veins. In fact, chronically elevated venous pressure was sufficient to cause the corkscrew-like enlargement of superficial veins in mice. We hypothesized that biomechanical activation of endothelial cells contributes to this process and investigated the inhibitory capacity of M… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 47 publications
1
11
0
Order By: Relevance
“…Indeed, risk factors causing increased pressure in the abdomen (e.g., obesity, pregnancy) may initiate and promote venous remodeling (Sisto et al, 1995 ; Pfisterer et al, 2014a ). In line with this idea, an increase in venous filling pressure alone supports enlargement and dilatation of superficial veins in mice (North and Sanders, 1958 ; Feldner et al, 2011 ; Kuk et al, 2017 ). In humans, pressure/wall stress-induced remodeling of superficial veins may in fact be explained by direct connection to the deep venous plexus as was evidenced by the increase in perfusion of a spider vein upon muscle contraction-mediated pressure increase in the deep veins.…”
Section: Discussionmentioning
confidence: 82%
See 3 more Smart Citations
“…Indeed, risk factors causing increased pressure in the abdomen (e.g., obesity, pregnancy) may initiate and promote venous remodeling (Sisto et al, 1995 ; Pfisterer et al, 2014a ). In line with this idea, an increase in venous filling pressure alone supports enlargement and dilatation of superficial veins in mice (North and Sanders, 1958 ; Feldner et al, 2011 ; Kuk et al, 2017 ). In humans, pressure/wall stress-induced remodeling of superficial veins may in fact be explained by direct connection to the deep venous plexus as was evidenced by the increase in perfusion of a spider vein upon muscle contraction-mediated pressure increase in the deep veins.…”
Section: Discussionmentioning
confidence: 82%
“…Despite the ambivalent effects of GA observed so far, it robustly inhibited the capacity of both human and mouse ECs and SMCs to degrade gelatin-based matrices. This inhibitory feature may in fact attenuate the renovation of the extracellular matrix in the context of venous remodeling which is usually associated with increased activity of matrix metalloproteinases (MMP-2/9) in animal models (Pascarella et al, 2005 ; Raffetto et al, 2008 ; Eschrich et al, 2016 ; Kuk et al, 2017 ) and diseased human veins (Woodside et al, 2003 ; Kowalewski et al, 2004 ; Nomura et al, 2005 ). As our findings did not reveal a GA-mediated down-regulation of the MMP2/9 expression, its observed gelatinase-inhibiting effect may be based on its direct interference with the enzymatic activity as has been described for many other enzymes such as 11beta-hydroxysteroid dehydrogenase (Monder et al, 1989 ), tyrosinase (Um et al, 2003 ), hyaluronidase (Hertel et al, 2006 ).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The possible underlying mechanism might be associated with the antiproliferative and antioxidative activity of magnolol through enhancement of HO-1 signaling and downregulation of cell proliferation, ERK1/2 activity, gelatinase activity, and ROS baseline production. However, the formation of endothelial capillary sprout is not influenced by magnolol [111]. In concanavalin A (ConA)-stimulated transformation from CD4+ T cells to CD4+T helper (Th17) cells in liver, magnolol significantly inhibits this cellular polarization, Th17 cell differentiation, and IL-17A production.…”
Section: Clinical Prospectivementioning
confidence: 99%